486 related articles for article (PubMed ID: 7826625)
21. TATA-binding protein activates transcription when upstream of a GCN4-binding site in a novel yeast promoter.
Brandl CJ; Martens JA; Liaw PC; Furlanetto AM; Wobbe CR
J Biol Chem; 1992 Oct; 267(29):20943-52. PubMed ID: 1400410
[TBL] [Abstract][Full Text] [Related]
22. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex.
Tanese N; Pugh BF; Tjian R
Genes Dev; 1991 Dec; 5(12A):2212-24. PubMed ID: 1748279
[TBL] [Abstract][Full Text] [Related]
23. Functions of the N- and C-terminal domains of human RAP74 in transcriptional initiation, elongation, and recycling of RNA polymerase II.
Lei L; Ren D; Finkelstein A; Burton ZF
Mol Cell Biol; 1998 Apr; 18(4):2130-42. PubMed ID: 9528785
[TBL] [Abstract][Full Text] [Related]
24. A nucleosome-positioning sequence is required for GCN4 to activate transcription in the absence of a TATA element.
Brandl CJ; Struhl K
Mol Cell Biol; 1990 Aug; 10(8):4256-65. PubMed ID: 2196450
[TBL] [Abstract][Full Text] [Related]
25. Multiple domains of the RNA polymerase I activator hUBF interact with the TATA-binding protein complex hSL1 to mediate transcription.
Jantzen HM; Chow AM; King DS; Tjian R
Genes Dev; 1992 Oct; 6(10):1950-63. PubMed ID: 1398072
[TBL] [Abstract][Full Text] [Related]
26. DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats.
Peterson SR; Dvir A; Anderson CW; Dynan WS
Genes Dev; 1992 Mar; 6(3):426-38. PubMed ID: 1547941
[TBL] [Abstract][Full Text] [Related]
27. Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID).
Hoffman A; Sinn E; Yamamoto T; Wang J; Roy A; Horikoshi M; Roeder RG
Nature; 1990 Jul; 346(6282):387-90. PubMed ID: 2374612
[TBL] [Abstract][Full Text] [Related]
28. Recombinant TBP, transcription factor IIB, and RAP30 are sufficient for promoter recognition by mammalian RNA polymerase II.
Killeen M; Coulombe B; Greenblatt J
J Biol Chem; 1992 May; 267(14):9463-6. PubMed ID: 1577790
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors.
Berger SL; Cress WD; Cress A; Triezenberg SJ; Guarente L
Cell; 1990 Jun; 61(7):1199-208. PubMed ID: 2163758
[TBL] [Abstract][Full Text] [Related]
30. A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1.
Peterson CL; Kruger W; Herskowitz I
Cell; 1991 Mar; 64(6):1135-43. PubMed ID: 2004420
[TBL] [Abstract][Full Text] [Related]
31. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator.
Webster N; Jin JR; Green S; Hollis M; Chambon P
Cell; 1988 Jan; 52(2):169-78. PubMed ID: 2830022
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID.
Smale ST; Schmidt MC; Berk AJ; Baltimore D
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4509-13. PubMed ID: 2141169
[TBL] [Abstract][Full Text] [Related]
33. A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives.
Carey M; Lin YS; Green MR; Ptashne M
Nature; 1990 May; 345(6273):361-4. PubMed ID: 2160609
[TBL] [Abstract][Full Text] [Related]
34. The interaction of RNA polymerase II with the adenovirus-2 major late promoter is precluded by phosphorylation of the C-terminal domain of subunit IIa.
Chesnut JD; Stephens JH; Dahmus ME
J Biol Chem; 1992 May; 267(15):10500-6. PubMed ID: 1316903
[TBL] [Abstract][Full Text] [Related]
35. [IIa/IIo conversion of RNA polymerase II during heat shock].
Dubois MF; Bensaude O; Morange M
C R Acad Sci III; 1991; 313(3):165-70. PubMed ID: 1913254
[TBL] [Abstract][Full Text] [Related]
36. A protein kinase that phosphorylates the C-terminal repeat domain of the largest subunit of RNA polymerase II.
Lee JM; Greenleaf AL
Proc Natl Acad Sci U S A; 1989 May; 86(10):3624-8. PubMed ID: 2657724
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells.
Müller-Immerglück MM; Schaffner W; Matthias P
EMBO J; 1990 May; 9(5):1625-34. PubMed ID: 2328728
[TBL] [Abstract][Full Text] [Related]
38. Mutations in RNA polymerase II enhance or suppress mutations in GAL4.
Allison LA; Ingles CJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2794-8. PubMed ID: 2495535
[TBL] [Abstract][Full Text] [Related]
39. Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s).
Muller M; Baniahmad C; Kaltschmidt C; Renkawitz R
Mol Endocrinol; 1991 Oct; 5(10):1498-503. PubMed ID: 1775133
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2.
Cisek LJ; Corden JL
Nature; 1989 Jun; 339(6227):679-84. PubMed ID: 2662013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
